A mouse study at Memorial Sloan Kettering Cancer Center has found that adding Nef, a protein from HIV, allows donor CAR T cells to avoid detection by the immune system while still attacking tumors.

Wiederhold, Ph.D., MBA, BCB, BCN is President of the Virtual Reality Medical Center (VRMC ... She has conducted over 10,000 VR therapy sessions and given invited lectures and training programs ...

CAR T cell therapy is one of the most promising new cancer treatments to emerge in recent years. It involves removing a patient's own immune T cells and engineering them to recognize specific targets ...